请使用支持JavaScript的浏览器! A rapid, quantitative and inexpensive method for detecting..._蚂蚁淘,【正品极速】生物医学科研用品轻松购|ebiomall -蚂蚁淘商城
当前位置: > 首页 > 技术文章 >
A rapid, quantitative and inexpensive method for detecting...
来自 : 蚂蚁淘

ASTRACT

Wedescribearapidandquantitativeflowcytometricmethodfordeterminingtheapoptoticoranti-apoptoticpotentialofageneinvariouscelltypes.Aplasmidcarryinggreenfluorescentprotein(GFP)isco-transfectedwithanexpressionvectorencodingthegeneofinterest.Subsequentlycellsarestainedwithpropidiumiodideand,utilisingflowcytometry,transfected,GFP-expressingsinglecellsaredetectedandapoptoticcellsinthispopulationareidentifiedbytheirDNAcontentof<2N.Themethoddetectsapoptosisasreliablyasestablishedmethodsusinginsitunick-endlabellingbutisfaster,easierandlessexpensive.

Apoptosisorprogrammedcelldeath(PCD)isageneticallycontrolledcellularsuicidemechanismforselectivelyeliminatingunwantedcells(forreviewssee1-4).PCDisanobligatoryprocessinavarietyofBIOLOGicalprocessesincludingembryonicandneuronaldevelopment,immunesystemregulation,organogenesis,tissuehomeostasisandinthepreventionofmalignanciessuchastumorgrowthandviralinfection.Apoptosisischaracterisedbyplasmamembraneblebbing,cellshrinkage,nuclearcondensation,endonucleolyticcleavageofgenomicDNAintointernucleosomallengthfragmentsandtheformationofapoptoticbodies.

Currentmethodsforstudyingapoptosisincludetheassessmentofmorphologicalchangesatthecellularlevelbylight-,electron-ortime-lapsemicroscopyincombinationwithvitalfluorescentdyes(reviewedin5,6),theuseofAnnexinVtomonitorthelossofmembranephospholipidasymmetryduringapoptosis(7)orassaystodetectDNAfragmentationbyagarosegelelectrophoresis(8-10),byinsitunick-endlabelling(TUNEL)(11),orbyusinganenzyme-linkedimmunoabsorbentassay(12).Mostofthesemethods,however,arecumbersome,inappropriateor,inthecaseoftheTUNELmethod,expensiveforstudyingtheeffectofputativecelldeathgenesintransienttransfectionassays.

Wehavedevelopedamethodsuitablefortheflowcytometricdeterminationofapoptosisinalargenumberofsamplesbypropidiumiodide(PI)inapopulationofcellstransientlyco-transfectedwithaplasmidencodingenhancedgreenfluorescentprotein(eGFP)(13)andaplasmidcarryingageneofinterest.ThisassaycombinestheFACS-optimisedGFPmutant(eGFP)(13)asaMarkertodetecttransientlytransfectedcellsandthereducedfluorescenceoftheDNA-bindingdyePIintheapoptoticsubpopulationasamarkerforapoptosis(14-17).ThereducedfluorescenceofPIinapoptosingcellsresultsintheappearanceofacharacteristicsub-2NfluorescencepeakwithrespecttotheG0/G1cellcycleregion.

Inordertovalidatethismethod,weinitiallyusedtheestablishedmurinetumorcelllines([beta]TCand[beta]HC)whichoriginatefrom[beta]celltumors(18)oftransgenicmiceinwhichtheinsulingeneregulatoryregion(Rip)targetstheexpressionofthesimianvirus40largeT-antigen(Tag)tothe[beta]cellsofthepancreaticislets(Rip1Tag2)(19).

Approximately80000cellswereseededina3cmdiameterwellofasix-welldishandgrowninDMEMsupplementedwith10%FCS(v/v),2mMglutamine,100IUpenicillinand100µg/mlstreptomycinto70%confluency.Cellsweretransfectedwith1µgofaplasmidencodingenhancedGFP(pEGFP-C1;Clontech)togetherwith1µgofeitheracontrolplasmid(pMEX),orapCMVplasmidcarryingeitherthepro-apoptoticadenovirusE1Aortheanti-apoptoticadenovirusE1B-19Kgene(20,21)using10µlLipofectAMINEReagent(Gibco-BRL)accordingtothemanufacturer"srecommendations.Followingtransfection,thecellswereallowedtorecoverincompletemediumfor16handweretheneitherleftuntreatedoranapoptoticstimulus(800ng/mlstaurosporine;Sigma)(22,23)wasaddedforanadditional16h.At32haftertransfection,floatingcellswerecollectedandcombinedwithtrypsinised,adherentcells,washedtwicewith4mlPBSandfixed[2%paraformaldehyde(PFA),100mMNaCl,300mMsucrose,3mMMgCl2,1mMEGTA,10mMPIPESpH6.8]atroomtemperaturefor30min,washedtwicewith4mlPBSandpost-fixedinice-cold70%EtOHfor10-14h.

Followingfixation,cellswerewashedtwicewith4mlPBSanddividedtoallowcomparisonofourmethodtothecommonlyusedmodifiedTUNELmethodusingfluorescentCy5-CTP.OnehalfofthesamplewastreatedwithRNaseA(50µg/ml)inPBSfor30min,washedtwicewith4mlPBSandstainedwithPI(50µg/ml)inPBSfor30minbeforeFACSanalysis.Theotherhalfofthesamplewasincubatedin50µlofterminaldeoxynucleotidyltransferase(TdT)reactionmixture(BoehringerMannheim;200mMpotassiumcacodylate,25mMTris-HClpH6.6,0.25mg/mlbovineserumalbumin,1mMCoCl2,0.25nmolofFluorOlinkCy5AP3-dCTP[Amersham],12.5UTdT)for1hat37°C.Thesamplewasthenwashedtwicewith4mlPBS,treatedwithRNaseA(50µg/ml)inPBSfor30min,washedtwicewith4mlHBS(Note:HBSisusedfromthissteponwardssinceDAPItendstocausemicro-precipitatesinPBS),stainedwithDAPI(10µg/ml;BoehringerMannheim)inHBSfor20minandanalysedonaBectonDickinsonFACSVantagemachine.FlowcytometricanalysisofthePI-stainedcellswascarriedoutonaBectonDickinsonFACScanequippedwithadoubletdiscriminationmodule.

AsshowninFigure1A,ourmethodreliablydetectstheexpectedapoptoticoranti-apoptoticeffectoftheadenovirusE1AorE1B-19Kgeneproducts,respectively(20,21).Theadditionofstaurosporinefollowingtransfectionfurtherexacerbatestheobservedeffects.SimilarresultsareobtainedusingfluorescentCy5-CTPandtheTdTreactiontomeasureapoptosis.AlthoughthesensitivityoftheGFP/PImethodisbelowthatoftheCy5-CTP/TdTmethod(Fig.1A),thenormalisedamountofapoptosis,expressedasaratiooftheapoptosismaximaobtainedwiththeE1Ageneproductwithineachdetectionmethod,isnearlyidentical(Fig.1B).

Figure1.Determinationofapoptosisintransientlytransfectedmurine[beta]tumorcells.(A)Thenumberofapoptotic[beta]HC13Ttumorcells(%apoptosis)inthetotaltransfectedeGFP-positivepopulationisshown.Co-transfectionsofpEGFPandtheplasmidsasindicatedwerecarriedoutusingLipofectAMINEasdescribedinthetext.ApoptoticcellsweremeasuredbyflowcytometricanalysiseitherusingPIstaininganddeterminationofsub-2NDNAcontent(GFP/PI;blackbars)orbytheincorporationoffluorescentCy5-CTPduringtheTdTreaction(GFP/TUNEL;whitebars).Staurosporine(800ng/ml)wasaddedfollowingtransfectionasindicated(+staurosporine).Excitationwavelengthof488nmwasusedforeGFPandPI,647nmforCy5andmultilineUVforDAPI.Emmisionfluorescencewascollectedusinga530/20nmbandpassfilterforeGFP,610nmlongpassfilterforPI,675/20nmbandpassfilterforCy5anda424/44nmbandpassfilterforDAPI.Doubletswereexcludedbypulseprocessing.CellsexpressingeGFPweregatedandanalysedforeitherCy5-orPI-fluorescence.DatawereanalysedusingCELLQuestsoftware(BectonDickinson).Eachbarrepresentstheaverageofthreetransfections,standarddeviationsareindicatedbyerrorbars.Eachmeasurementincluded40000totaleventsgatedforsizeandsinglecells.Transfectionefficiencywas20-30%.(B)Thenormalisedpercentageofapoptosisisshownforthevariousconstructs.Theapoptoticindexwasnormalisedusingthefunction(%apopotosisinX/%apoptosisineGFP-C1/E1A)×100.Theapoptoticindexwasnormalisedforeachdetectionmethodusedandforeachpost-transfectiontreatmentemployed(i.e.+/-staurosporine).Notethepro-apoptoticandanti-apoptoticeffectofE1AandE1B-19K,respectively.

Todemonstratethegeneralusefulnessofourassay,theGFP/PImethodwastestedonanon-transformedratfibroblastcellline(Rat1A)whichislesssensitivetoapoptoticstimuli.Rat1AcellsweretransientlytransfectedusingeitherLipofectAMINEasdescribedforthe[beta]tumorcellsabove,orpolyethylenimine-(PEI2000)-DNA-adenoviruscomplexesasdescribed(24).AcomparisonofthedifferenttransfectionandapoptoticdetectionmethodsusingRat1AcellsispresentedinTable1.Asobservedwiththe[beta]tumorcelllines,theGFP/PImethodisareliableapoptoticassayfortransientlytransfectedRat1Acells(Table1)aswellasforahumanlungcarcinomacelllineA549(ATCCCCL-185)(24).

Table1.DeterminationofapoptosisinRat1Acells

TransfectedPropidiumIodidebTUNELc
Constructa%Apoptosis(s.d.)%ApoptosisNormalisedd%Apoptosis(s.d.)%ApoptosisNormalised
LipofectAMINEReagent
pMEX(Ctr)3.3(0.7)68.86.5(0.6)71.4
pE1B-19K1.4(0.3)29.22.2(0.5)24.2
pE1A4.8(0.4)1009.1(2.6)100
PEI/Adeno
pMEX(Ctr)1.2(0.2)52.27.5(3.0)52.1
pE1B-19K0.7(0.1)30.45.2(0.8)36.1
pE1A2.3(0.6)10014.4(2.7)100
aTransfectionofRat1AcellswithpEGFP-C1andtheconstructsasindicatedusingeitherLipofectAMINEReagentorPEI(2000)-DNA-adenoviruscomplexes.Followingtransfectionthecellsweretreatedwithstaurosporine(800ng/ml)for16h.TheapoptoticindexofthetransfectedcellswasanalysedbyflowcytometryasdescribedinthetextandinthelegendtoFigure1.Eachvaluerepresentstheaverageofthreetransfections,standarddeviationisindicated(s.d.).Transfectionefficiencywas25-30%bothusingLipofectAMINEandPEI/Adeno.bTheapoptoticindexofeGFP-positivecellswasdeterminedbyPIstainingandsub-2NDNAcontent.cTheapoptoticindexofeGFP-positivecellswasdeterminedbytheincorporationoffluorescentCy5-CTPduringtheTUNELreaction.dThenormalisedapoptoticindexwascalculatedasdescribedinthelegendtoFigure1.

ThePFA/EtOHfixationprocedureusedinourprotocolisessential.OmissionofthemildPFAfixationstepleadstotherapidleakageofeGFPfromthecellandimpairsdetectionoftransientlytransfectedcells.TheEtOHfixation/permeABIlisationstepallowsdiffusionoflowmolecularweightDNAproductsfromapoptoticcellsandisrequiredtodetectthecharacteristicsub-2NDNApeakuponPIstaining(6,17).

Inconclusion,wepresentarapid,efficientandreproducIBLemethodfordeterminingtheapoptoticpotentialofagivengeneofinterestinavarietyofcelllines.Ourmethodisapplicabletoandcompatiblewithavarietyofcelltypesandtransfectionmethods.ItcombinestheeaseofusingGFPasamarkerfortransfectionandsub-2NPIstainingasasimple,inexpensiveassayforapoptosis.FurThermore,thisassaycanbecarriedoutonarelativelysimpleFACScananalyseranddoesnotrequireelaborateFACSsortertechnologyorexpertise.

ACKNOWLEDGEMENTS

TheauthorswishtothankJohannesHoffmanforprovidingtheTdT/Cy5-CTPprotocolforFACSanalyses,EileenWhiteforpCMV-E1AandpCMV-E1B-19KandThomasBaderandKanagaSabapathyforcriticalreADIngofthemanuscript.ThisworkwassupportedinpartbytheAustrianIndustrialPromotionFund.

REFERENCES

1Korsmeyer,S.J.(1995)TrendsGenet.,11,101-105.MEDLINEAbstract

2Chinnaiyan,A.M.andDixit,V.M.(1996)Curr.Biol.,6,555-562.MEDLINEAbstract

3Vaux,D.L.andStrasser,A.(1996)Proc.Natl.Acad.Sci.USA,93,2239-2244.MEDLINEAbstract

4White,E.(1996)GenesDev.,10,1-15.MEDLINEAbstract

5Kerr,J.F.R.,Gobé,G.C.,Winterford,C.M.andHarmon,B.V.(1995)InSchwartz,L.M.andOsborne,B.A.(eds.),CellDeath.AcademicPress,Inc.,SanDiego,Vol.46,pp.1-27.

6McGahon,A.J.,Martin,S.J.,Bissonnette,R.P.,Mahboubi,A.,Shi,Y.,Mogil,R.J.,Nishioka,W.K.andGreen,D.R.(1995)InSchwartz,L.M.andOsborne,B.A.(eds.),CellDeath.AcademicPress,Inc.,SanDiego,Vol.46,pp.153-185.

7Koopman,G.,Reutelingsperger,C.P.,Kuijten,G.A.,Keehnen,R.M.,Pals,S.T.andvanOers,M.J.(1994)Blood,84,1415-1420.MEDLINEAbstract

8Wyllie,A.H.(1980)Nature,284,555-556.MEDLINEAbstract

9Eldadah,B.A.,Yakovlev,A.G.andFaden,A.I.(1996)NucleicAcidsRes.,24,4092-4093.MEDLINEAbstract

10Ioannou,Y.I.andChen,F.W.(1996)NucleicAcidsRes.,24,992-993.

11Gavrieli,Y.,Sherman,Y.andBen-Sasson,S.A.(1992)J.CellBiol.,119,493-501.MEDLINEAbstract

12Salgame,P.S.,Varadcgacgary,A.S.,Primiano,L.L.,Fincke,J.E.,Muller,S.andMonestier,M.(1997)NucleicAcidsRes.,25,680-681.

13Cormack,B.P.,Valdivia,R.H.andFalkow,S.(1996)Gene,173,33-38.MEDLINEAbstract

14Nicoletti,I.,Migliorati,G.,Pagliacci,M.C.,Grignani,F.andRiccardi,C.(1991)J.Immunol.Methods,139,271-279.MEDLINEAbstract

15Telford,W.G.,King,L.E.andFraker,P.J.(1991)CellProlif.,24,447-459.MEDLINEAbstract

16Telford,W.G.,King,L.E.andFraker,P.J.(1992)Cytometry,13,137-143.MEDLINEAbstract

17Darzynkiewicz,Z.,Bruno,S.,DelBino,G.,Gorczyca,W.,Hotz,M.A.,Lassota,P.andTraganos,F.(1992)Cytometry,13,795-808.MEDLINEAbstract

18Radvanyi,F.,Christgau,S.,Baekkeskov,S.,Jolicoeur,C.andHanahan,D.(1993)Mol.Cell.Biol.,13,4223-4232.MEDLINEAbstract

19Hanahan,D.(1985)Nature,315,115-121.MEDLINEAbstract

20White,E.,Cipriani,R.,Sabbatini,P.andDenton,A.(1991)J.Virol.,65,2968-2978.MEDLINEAbstract

21White,E.andCipriani,R.(1990)Mol.Cell.Biol.,10,120-130.MEDLINEAbstract

22Jacobsen,M.D.,Weil,M.andRaff,M.C.(1996)J.CellBiol.,133,1041-1051.MEDLINEAbstract

23Raff,M.C.,Barres,B.A.,Burne,J.F.,Coles,H.S.,Ishizaki,Y.andJacobson,M.D.(1993)Science,262,695-700.MEDLINEAbstract

24Baker,A.,Saltik,M.,Lehrmann,H.,Killisch,I.,Mautner,V.,Lamm,G.,Christofori,G.andCotten,M.(1997)GeneTherapy,4,773-782.MEDLINEAbstract

免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
相关文章